Avalo Therapeutics (AVTX) Other Accumulated Expenses (2021 - 2026)
Avalo Therapeutics' Other Accumulated Expenses came in at $327,000 for Q1 2026, unchanged from $327,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
Going back to Q3 2021, Avalo Therapeutics' Other Accumulated Expenses data covers 16 quarters.
- Other Accumulated Expenses carries a four-year compound annual growth rate of -3.4% (FY2021 to FY2025).
- Going back by year, Other Accumulated Expenses was $327,000 in FY2024, $508,000 in FY2022 (+35.5%) and $375,000 in FY2021.
- The five-year range for quarterly Other Accumulated Expenses is $214,000 (Q3 2023) to $653,000 (Q3 2021).
- Year-over-year, Other Accumulated Expenses increased in two of the last four quarters, with growth averaging 12.1%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q2 2023 (growth of 115.2%), and the weakest in Q3 2023 (a decline of 46.4%).
- Business Quant data shows AVTX's Other Accumulated Expenses at $327,000 (Q4 2025), $327,000 (Q3 2025) and $327,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Avalo Therapeutics | 386.09 Mn | -587.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 327,000.00 |
| Dec 31, 2025 | 327,000.00 |
| Sep 30, 2025 | 327,000.00 |
| Jun 30, 2025 | 327,000.00 |
| Mar 31, 2025 | 327,000.00 |
| Dec 31, 2024 | 327,000.00 |
| Sep 30, 2024 | 241,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 607,000.00 |
| Mar 31, 2023 | 445,000.00 |
| Dec 31, 2022 | 508,000.00 |
| Sep 30, 2022 | 399,000.00 |
| Jun 30, 2022 | 282,000.00 |
| Mar 31, 2022 | 440,000.00 |
| Dec 31, 2021 | 375,000.00 |
| Sep 30, 2021 | 653,000.00 |
API Access
Avalo Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();